{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T20:55:06Z","timestamp":1787950506697,"version":"build-2784847793"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T00:00:00Z","timestamp":1616716800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T00:00:00Z","timestamp":1616716800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s10072-021-05191-5","type":"journal-article","created":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T09:02:44Z","timestamp":1616749364000},"page":"5093-5100","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Serum transthyretin and risk of cognitive decline and dementia: 22-year longitudinal study"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4814-5463","authenticated-orcid":false,"given":"Marzieh","family":"Araghi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin J.","family":"Shipley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atul","family":"Anand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas L.","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"Kivimaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archana","family":"Singh-Manoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Tab\u00e1k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9verine","family":"Sabia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric J.","family":"Brunner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,26]]},"reference":[{"issue":"1","key":"5191_CR1","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/S1474-4422(18)30403-4","volume":"18","author":"GBDD Collaborators","year":"2019","unstructured":"Collaborators GBDD (2019) Global, regional, and national burden of Alzheimer\u2019s disease and other dementias, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 18(1):88\u2013106. https:\/\/doi.org\/10.1016\/S1474-4422(18)30403-4","journal-title":"Lancet Neurol"},{"issue":"2","key":"5191_CR2","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.pharep.2014.09.004","volume":"67","author":"A Kumar","year":"2015","unstructured":"Kumar A, Singh A, Ekavali (2015) A review on Alzheimer\u2019s disease pathophysiology and its management: an update. Pharmacol Rep 67(2):195\u2013203. https:\/\/doi.org\/10.1016\/j.pharep.2014.09.004","journal-title":"Pharmacol Rep"},{"issue":"5","key":"5191_CR3","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.neurobiolaging.2006.03.015","volume":"28","author":"JC Sousa","year":"2007","unstructured":"Sousa JC, Cardoso I, Marques F, Saraiva MJ, Palha JA (2007) Transthyretin and Alzheimer\u2019s disease: where in the brain? Neurobiol Aging 28(5):713\u2013718. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2006.03.015","journal-title":"Neurobiol Aging"},{"issue":"4","key":"5191_CR4","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack Jr","year":"2018","unstructured":"Jack CR Jr, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, Holtzman DM, Jagust W, Jessen F, Karlawish J, Liu E, Molinuevo JL, Montine T, Phelps C, Rankin KP, Rowe CC, Scheltens P, Siemers E, Snyder HM, Sperling R, Contributors (2018) NIA-AA Research Framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement 14(4):535\u2013562. https:\/\/doi.org\/10.1016\/j.jalz.2018.02.018","journal-title":"Alzheimers Dement"},{"key":"5191_CR5","doi-asserted-by":"publisher","first-page":"20164","DOI":"10.1038\/srep20164","volume":"6","author":"M Alemi","year":"2016","unstructured":"Alemi M, Gaiteiro C, Ribeiro CA, Santos LM, Gomes JR, Oliveira SM, Couraud PO, Weksler B, Romero I, Saraiva MJ, Cardoso I (2016) Transthyretin participates in beta-amyloid transport from the brain to the liver--involvement of the low-density lipoprotein receptor-related protein 1? Sci Rep 6:20164. https:\/\/doi.org\/10.1038\/srep20164","journal-title":"Sci Rep"},{"issue":"4","key":"5191_CR6","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1111\/j.1460-9568.2004.03563.x","volume":"20","author":"JP Corcoran","year":"2004","unstructured":"Corcoran JP, So PL, Maden M (2004) Disruption of the retinoid signalling pathway causes a deposition of amyloid beta in the adult rat brain. Eur J Neurosci 20(4):896\u2013902. https:\/\/doi.org\/10.1111\/j.1460-9568.2004.03563.x","journal-title":"Eur J Neurosci"},{"issue":"2","key":"5191_CR7","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.clnu.2016.06.004","volume":"36","author":"S Delliere","year":"2017","unstructured":"Delliere S, Cynober L (2017) Is transthyretin a good marker of nutritional status? Clin Nutr 36(2):364\u2013370. https:\/\/doi.org\/10.1016\/j.clnu.2016.06.004","journal-title":"Clin Nutr"},{"key":"5191_CR8","doi-asserted-by":"publisher","unstructured":"Giao T, Saavedra J, Cotrina E, Quintana J, Llop J, Arsequell G, Cardoso I (2020) Undiscovered roles for transthyretin: from a transporter protein to a new therapeutic target for Alzheimer\u2019s disease. Int J Mol Sci 21(6). https:\/\/doi.org\/10.3390\/ijms21062075","DOI":"10.3390\/ijms21062075"},{"issue":"1","key":"5191_CR9","doi-asserted-by":"publisher","first-page":"18691","DOI":"10.1038\/s41598-019-55318-0","volume":"9","author":"YT Tien","year":"2019","unstructured":"Tien YT, Lee WJ, Liao YC, Wang WF, Jhang KM, Wang SJ, Fuh JL (2019) Plasma transthyretin as a predictor of amnestic mild cognitive impairment conversion to dementia. Sci Rep 9(1):18691. https:\/\/doi.org\/10.1038\/s41598-019-55318-0","journal-title":"Sci Rep"},{"issue":"2","key":"5191_CR10","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3233\/JAD-2011-110611","volume":"28","author":"L Velayudhan","year":"2012","unstructured":"Velayudhan L, Killick R, Hye A, Kinsey A, Guntert A, Lynham S, Ward M, Leung R, Lourdusamy A, To AW, Powell J, Lovestone S (2012) Plasma transthyretin as a candidate marker for Alzheimer\u2019s disease. J Alzheimers Dis 28(2):369\u2013375. https:\/\/doi.org\/10.3233\/JAD-2011-110611","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"5191_CR11","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1093\/ije\/dyh372","volume":"34","author":"M Marmot","year":"2005","unstructured":"Marmot M, Brunner E (2005) Cohort Profile: the Whitehall II study. Int J Epidemiol 34(2):251\u2013256. https:\/\/doi.org\/10.1093\/ije\/dyh372","journal-title":"Int J Epidemiol"},{"issue":"1","key":"5191_CR12","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1477-5956-11-10","volume":"11","author":"S Pasella","year":"2013","unstructured":"Pasella S, Baralla A, Canu E, Pinna S, Vaupel J, Deiana M, Franceschi C, Baggio G, Zinellu A, Sotgia S, Castaldo G, Carru C, Deiana L (2013) Pre-analytical stability of the plasma proteomes based on the storage temperature. Proteome Sci 11(1):10. https:\/\/doi.org\/10.1186\/1477-5956-11-10","journal-title":"Proteome Sci"},{"issue":"8","key":"5191_CR13","doi-asserted-by":"publisher","first-page":"e1002862","DOI":"10.1371\/journal.pmed.1002862","volume":"16","author":"A Sommerlad","year":"2019","unstructured":"Sommerlad A, Sabia S, Singh-Manoux A, Lewis G, Livingston G (2019) Association of social contact with dementia and cognition: 28-year follow-up of the Whitehall II cohort study. PLoS Med 16(8):e1002862. https:\/\/doi.org\/10.1371\/journal.pmed.1002862","journal-title":"PLoS Med"},{"key":"5191_CR14","doi-asserted-by":"publisher","first-page":"j2709","DOI":"10.1136\/bmj.j2709","volume":"357","author":"S Sabia","year":"2017","unstructured":"Sabia S, Dugravot A, Dartigues JF, Abell J, Elbaz A, Kivimaki M, Singh-Manoux A (2017) Physical activity, cognitive decline, and risk of dementia: 28 year follow-up of Whitehall II cohort study. BMJ 357:j2709. https:\/\/doi.org\/10.1136\/bmj.j2709","journal-title":"BMJ"},{"issue":"5","key":"5191_CR15","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1002\/ana.21509","volume":"64","author":"H Amieva","year":"2008","unstructured":"Amieva H, Le Goff M, Millet X, Orgogozo JM, Peres K, Barberger-Gateau P, Jacqmin-Gadda H, Dartigues JF (2008) Prodromal Alzheimer\u2019s disease: successive emergence of the clinical symptoms. Ann Neurol 64(5):492\u2013498. https:\/\/doi.org\/10.1002\/ana.21509","journal-title":"Ann Neurol"},{"key":"5191_CR16","doi-asserted-by":"publisher","first-page":"j2856","DOI":"10.1136\/bmj.j2856","volume":"358","author":"S Ahmadi-Abhari","year":"2017","unstructured":"Ahmadi-Abhari S, Guzman-Castillo M, Bandosz P, Shipley MJ, Muniz-Terrera G, Singh-Manoux A, Kivimaki M, Steptoe A, Capewell S, O'Flaherty M, Brunner EJ (2017) Temporal trend in dementia incidence since 2002 and projections for prevalence in England and Wales to 2040: modelling study. BMJ 358:j2856. https:\/\/doi.org\/10.1136\/bmj.j2856","journal-title":"BMJ"},{"issue":"3","key":"5191_CR17","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41591-020-0755-1","volume":"26","author":"S Janelidze","year":"2020","unstructured":"Janelidze S, Mattsson N, Palmqvist S, Smith R, Beach TG, Serrano GE, Chai X, Proctor NK, Eichenlaub U, Zetterberg H, Blennow K, Reiman EM, Stomrud E, Dage JL, Hansson O (2020) Plasma P-tau181 in Alzheimer\u2019s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer\u2019s dementia. Nat Med 26(3):379\u2013386. https:\/\/doi.org\/10.1038\/s41591-020-0755-1","journal-title":"Nat Med"},{"issue":"12","key":"5191_CR18","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1016\/j.bbadis.2013.09.011","volume":"1832","author":"R Cascella","year":"2013","unstructured":"Cascella R, Conti S, Mannini B, Li X, Buxbaum JN, Tiribilli B, Chiti F, Cecchi C (2013) Transthyretin suppresses the toxicity of oligomers formed by misfolded proteins in vitro. Biochim Biophys Acta 1832(12):2302\u20132314. https:\/\/doi.org\/10.1016\/j.bbadis.2013.09.011","journal-title":"Biochim Biophys Acta"},{"issue":"12","key":"5191_CR19","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1016\/j.clinbiochem.2005.08.007","volume":"38","author":"S Giunta","year":"2005","unstructured":"Giunta S, Valli MB, Galeazzi R, Fattoretti P, Corder EH, Galeazzi L (2005) Transthyretin inhibition of amyloid beta aggregation and toxicity. Clin Biochem 38(12):1112\u20131119. https:\/\/doi.org\/10.1016\/j.clinbiochem.2005.08.007","journal-title":"Clin Biochem"},{"issue":"50","key":"5191_CR20","doi-asserted-by":"publisher","first-page":"19423","DOI":"10.1523\/JNEUROSCI.2561-13.2013","volume":"33","author":"X Li","year":"2013","unstructured":"Li X, Zhang X, Ladiwala AR, Du D, Yadav JK, Tessier PM, Wright PE, Kelly JW, Buxbaum JN (2013) Mechanisms of transthyretin inhibition of beta-amyloid aggregation in vitro. J Neurosci 33(50):19423\u201319433. https:\/\/doi.org\/10.1523\/JNEUROSCI.2561-13.2013","journal-title":"J Neurosci"},{"issue":"33","key":"5191_CR21","doi-asserted-by":"publisher","first-page":"5029","DOI":"10.1021\/acs.biochem.8b00517","volume":"57","author":"P Mangrolia","year":"2018","unstructured":"Mangrolia P, Murphy RM (2018) Retinol-binding protein interferes with transthyretin-mediated beta-amyloid aggregation inhibition. Biochemistry 57(33):5029\u20135040. https:\/\/doi.org\/10.1021\/acs.biochem.8b00517","journal-title":"Biochemistry"},{"issue":"12","key":"5191_CR22","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1111\/cns.12476","volume":"21","author":"A Martorana","year":"2015","unstructured":"Martorana A, Di Lorenzo F, Belli L, Sancesario G, Toniolo S, Sallustio F, Sancesario GM, Koch G (2015) Cerebrospinal Fluid Abeta42 Levels: When physiological become pathological state. CNS Neurosci Ther 21(12):921\u2013925. https:\/\/doi.org\/10.1111\/cns.12476","journal-title":"CNS Neurosci Ther"},{"key":"5191_CR23","doi-asserted-by":"publisher","first-page":"254","DOI":"10.3389\/fnagi.2014.00254","volume":"6","author":"A Martorana","year":"2014","unstructured":"Martorana A, Di Lorenzo F, Manenti G, Semprini R, Koch G (2014) Homotaurine induces measurable changes of short latency afferent inhibition in a group of mild cognitive impairment individuals. Front Aging Neurosci 6:254. https:\/\/doi.org\/10.3389\/fnagi.2014.00254","journal-title":"Front Aging Neurosci"},{"issue":"2","key":"5191_CR24","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3233\/JAD-2009-0966","volume":"16","author":"SF Hansson","year":"2009","unstructured":"Hansson SF, Andreasson U, Wall M, Skoog I, Andreasen N, Wallin A, Zetterberg H, Blennow K (2009) Reduced levels of amyloid-beta-binding proteins in cerebrospinal fluid from Alzheimer\u2019s disease patients. J Alzheimers Dis 16(2):389\u2013397. https:\/\/doi.org\/10.3233\/JAD-2009-0966","journal-title":"J Alzheimers Dis"},{"issue":"8","key":"5191_CR25","doi-asserted-by":"publisher","first-page":"881","DOI":"10.2174\/156720512803251057","volume":"9","author":"CA Ribeiro","year":"2012","unstructured":"Ribeiro CA, Santana I, Oliveira C, Baldeiras I, Moreira J, Saraiva MJ, Cardoso I (2012) Transthyretin decrease in plasma of MCI and AD patients: investigation of mechanisms for disease modulation. Curr Alzheimer Res 9(8):881\u2013889. https:\/\/doi.org\/10.2174\/156720512803251057","journal-title":"Curr Alzheimer Res"},{"issue":"1","key":"5191_CR26","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3233\/JAD-2011-102145","volume":"25","author":"SH Han","year":"2011","unstructured":"Han SH, Jung ES, Sohn JH, Hong HJ, Hong HS, Kim JW, Na DL, Kim M, Kim H, Ha HJ, Kim YH, Huh N, Jung MW, Mook-Jung I (2011) Human serum transthyretin levels correlate inversely with Alzheimer's disease. J Alzheimers Dis 25(1):77\u201384. https:\/\/doi.org\/10.3233\/JAD-2011-102145","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"5191_CR27","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1179\/016164106X98035","volume":"28","author":"EM Castano","year":"2006","unstructured":"Castano EM, Roher AE, Esh CL, Kokjohn TA, Beach T (2006) Comparative proteomics of cerebrospinal fluid in neuropathologically-confirmed Alzheimer\u2019s disease and non-demented elderly subjects. Neurol Res 28(2):155\u2013163. https:\/\/doi.org\/10.1179\/016164106X98035","journal-title":"Neurol Res"},{"issue":"4","key":"5191_CR28","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1080\/13506120802525285","volume":"15","author":"J Buxbaum","year":"2008","unstructured":"Buxbaum J, Koziol J, Connors LH (2008) Serum transthyretin levels in senile systemic amyloidosis: effects of age, gender and ethnicity. Amyloid 15(4):255\u2013261. https:\/\/doi.org\/10.1080\/13506120802525285","journal-title":"Amyloid"},{"issue":"2","key":"5191_CR29","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3109\/13506129.2010.483118","volume":"17","author":"J Buxbaum","year":"2010","unstructured":"Buxbaum J, Anan I, Suhr O (2010) Serum transthyretin levels in Swedish TTR V30M carriers. Amyloid 17(2):83\u201385. https:\/\/doi.org\/10.3109\/13506129.2010.483118","journal-title":"Amyloid"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-021-05191-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-021-05191-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-021-05191-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,3]],"date-time":"2021-12-03T21:08:29Z","timestamp":1638565709000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-021-05191-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,26]]},"references-count":29,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["5191"],"URL":"https:\/\/doi.org\/10.1007\/s10072-021-05191-5","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,26]]},"assertion":[{"value":"5 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"University College London Hospital Committee on the Ethics of Human Research, reference 85\/0938.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors give their consent for the publication of identifiable details of this paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}